Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Investor Relations

View Investor Relations

Latest News

Ligand to Report Third Quarter 2018 Results on November 8th

Read More

Ligand Announces the Close of its Acquisition of Vernalis

Read More

Ligand to Participate in H.C. Wainwright 20th Annual Global Investment Conference

Read More

Recent Events

Upcoming Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range